אגף רשות המחקר

לוח קולות קוראים

פברואר 2027

א'	ב'	ג'	ד'	ה'	ו'	ש'
31	1	2	3	4	5	6

7	8 BRAIN Initiative: Development and Validation of Novel Tools to Probe Cell-Specific and Circuit-Specific Processes in the Brain (R01) National Institutes of Health (NIH) Translational Bioinformatics and Experimental Approaches to Advance Drug Repositioning and Combination Therapy Development for Alzheimer’s Disease and Related Dementias (R01) National Institutes of Health (NIH)	9	10	11 NIDA Animal Genomics Program (U01) National Institute on Drug Abuse/NIH	12 NIDCD Research Grants for Translating Basic Research into Clinical Practice (R01) National Institute on Deafness and Other Communication Disorders/NIH	13
	Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Neurotherapeutic Agent Characterization and In vivo Efficacy Studies (R61/R33) National Institute of Neurological Disorders and Stroke/NIH Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Neurotherapeutic Agent Characterization and In vivo Efficacy Studies (R61/R33) National Institute of Neurological Disorders and Stroke/NIH			Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Neurotherapeutic Agent Characterization and In vivo Efficacy Studies (R61/R33) National Institute of Neurological Disorders and Stroke/NIH	Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Neurotherapeutic Agent Characterization and In vivo Efficacy Studies (R61/R33) National Institute of Neurological Disorders and Stroke/NIH
14	15	16	17	18 Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Development and Validation of Model Systems to Facilitate Neurotherapeutic Discovery (R61/R33) National Institute of Neurological Disorders and Stroke/NIH Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Assay Development and Neurotherapeutic Agent Identification (R61/R33) National Institutes of Health (NIH) Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Neurotherapeutic Agent Characterization and In vivo Efficacy Studies (R61/R33) National Institute of Neurological Disorders and Stroke/NIH Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Neurotherapeutic Agent Characterization and In vivo Efficacy Studies (R61/R33) National Institute of Neurological Disorders and Stroke/NIH	19	20
				Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Neurotherapeutic Agent Characterization and In vivo Efficacy Studies (R61/R33) National Institute of Neurological Disorders and Stroke/NIH Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Neurotherapeutic Agent Characterization and In vivo Efficacy Studies (R61/R33) National Institute of Neurological Disorders and Stroke/NIH Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Neurotherapeutic Agent Characterization and In vivo Efficacy Studies (R61/R33) National Institute of Neurological Disorders and Stroke/NIH Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Neurotherapeutic Agent Characterization and In vivo Efficacy Studies (R61/R33) National Institute of Neurological Disorders and Stroke/NIH
21	22	23	24	25	26	27

28	1	2	3	4	5	6